Related Experiment Video
Updated: Jun 6, 2025
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
[Advances in prostate cancer biomarkers]
Zibin Chu1, Ye Xu1, Ziqiang Yin1
1Innovation Center of Molecular Diagnostics, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|November 25, 2024
Summary
Developing novel prostate cancer biomarkers is crucial for early detection and improved patient outcomes. This review highlights the need for specific, cost-effective, and non-invasive methods to enhance prostate cancer screening and diagnosis.
Area of Science:
- Oncology
- Biomarker Discovery
- Diagnostic Methods
Background:
- Prostate cancer is a significant health concern for men worldwide.
- Current screening methods like prostate-specific antigen (PSA) testing, biopsy, and MRI lack specificity and carry risks.
- There is a critical need for improved, non-invasive biomarkers for accurate prostate cancer diagnosis and prognosis.
Purpose of the Study:
- To review recent advancements in prostate cancer biomarkers.
- To analyze and compare various biomarkers and combined detection strategies.
- To identify future research directions and challenges in prostate cancer diagnostics.
Main Methods:
- Comprehensive literature review of prostate cancer biomarkers.
- Analysis of current diagnostic and prognostic assessment methods.
- Comparative evaluation of biomarker efficacy and clinical applicability.
Main Results:
- Existing prostate cancer detection methods have limitations in specificity, cost, and risk.
- Emerging biomarkers and combined approaches show promise for improved accuracy.
- The development of efficient, cost-effective, and easily accessible biomarkers is paramount.
Conclusions:
- Novel biomarkers are essential for enhancing early prostate cancer diagnosis rates.
- Improved diagnostic tools can lead to better patient prognosis and reduced healthcare costs.
- This review provides a foundation for future research and clinical application in prostate cancer management.
